-transparent.png){kind=logo}
Vagal nerve stimulation is an emerging therapy for epilepsy, yet little is known regarding the effects of this stimulation on heart period variability. We selected 10 patients (two female, eight male) who were receiving high-frequency, high-intensity left vagal nerve stimulation for intractable epilepsy. Electrocardiogram data were recorded for a 7 min baseline, 2.5 min of stimulation and a 7 min post-stimulation period. We found no significant changes in average heart period, instantaneous changes of successive R-to-R intervals greater than 50 ms or fractal dimension. We also found no significant changes in the total power in the 0.0-0.04 Hz, 0.04-0.12 Hz and 0.2-0.4 Hz bands with stimulation of the left vagus nerve. This study suggests that left vagal nerve stimulation has little acute effect on the cardiac rhythm or heart period variability.
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
February 2015,
European heart journal,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
May 2010,
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
April 2009,
Epilepsia,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
January 2023,
Surgical neurology international,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
June 2016,
Nature reviews. Cardiology,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
March 1984,
Psychophysiology,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
July 2022,
Biological psychology,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
August 1971,
The American journal of physiology,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
July 2004,
Circulation,
A B Setty, and
B V Vaughn, and
S R Quint, and
K R Robertson, and
J A Messenheimer
January 2014,
American journal of therapeutics,
